β¨ Medicines Distribution Consents
NEW ZEALAND GAZETTE
No. 30
1246
Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)
--- | --- | --- | ---
Human Menopausal Gonadotrophin FSH 75IU/LH 35IU, FSH 150IU/LH 70IU. Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 February 1994, No. 16, page 909, notice number 1435. | Lyophilisate for IM injection | Industria Farmaceutica Serono, Roma, Italy and Laboratoires Serona SA, Aubonne, Switzerland | Pergogreen
Dated this 28th day of March 1994.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
g02463
Consent to the Distribution of a New Related Product
Pursuant to section 96 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)
--- | --- | --- | ---
Ascorbic acid 90 mg, biotin 25 mcg, calcium pantothenate 10 mg, chromium (as chromium yeast) 20 mcg, copper (as copper gluconate) 2 mg, calcium (as calcium phosphate and calcium hydrogen phosphate) 200 mg, iron (as ferrous fumarate and iron) 5 mg, folic acid 400 mcg, magnesium (as magnesium oxide) 100 mg, molybdenum (as molybdenum yeast) 20 mcg, nicotinamide 20 mg, potassium (as potassium chloride) 10 mg, iodine (as potassium iodide) 150 mcg, pyridoxine hydrochloride 2 mg, riboflavin 2.6 mg, thiamine nitrate 2.3 mg, retinol 1500 mcg, cyanocobalamin 9 mcg, d-Ξ±-tocopherol and d-Ξ±-tocopheryl succinate 20 mg, zinc (as zinc oxide) 15 mg, cholecalciferol 10 mcg, phosphorus (as calcium phosphate and calcium hydrogen phosphate) 125 mg, manganese (as manganese sulphate) 5 mg | Tablet | Nutrilite Products Inc., Buena Park, California, United States of America | Nutriway Daily
Dated this 28th day of March 1994.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
g02461
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1994, No 30
NZLII —
NZ Gazette 1994, No 30
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare28 March 1994
Medicines, Distribution, Consent, Medicines Act, Human Menopausal Gonadotrophin
- C. Lovelace, Director-General of Health
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social Welfare28 March 1994
Medicines, Distribution, Consent, Medicines Act, Nutrilite Products, Nutriway Daily
- C. Lovelace, Director-General of Health
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social WelfareMedicines, Distribution, Provisional Consent, Medicines Act